Genentech Oct 29, 2020 Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC Oct 27, 2020 FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Three Targeted Therapies May 18, 2020 Genentech's Tecentriq Receives First-Line FDA Approval for High PD-L1-Expressing Lung Cancer Mar 4, 2020 Pulmonary Fibrosis Foundation, Celgene Form Biomarker Consortium Jan 13, 2020 Adaptive Biotechnologies, Genentech Partner on MRD Testing in Venetoclax Clinical Trial Sep 5, 2019 Abionic, Genentech Partner to Develop POC Asthma Test Aug 16, 2019 Foundation Medicine to Seek FDA Approval for FoundationOne as CDx to Genentech's Rozlytrek Jan 9, 2019 Adaptive Biotechnologies to Leverage Genentech, Microsoft Deals to Advance Immune Profiling Business Aug 6, 2018 Study Describes Design, Validation of Foundation Medicine's Blood-Based TMB Test Jun 27, 2018 Boost in Use of Biomarker-Based Alzheimer's Diagnostics Expected From Shift in Guidance Premium Apr 17, 2018 At AACR, Immuno-Oncology Clinical Trials Offer Mixed Messages on Predictive Biomarkers Premium Jan 24, 2017 Outgoing FDA Commissioner, Pharma, Investors Discuss Regulation at Personalized Medicine Meeting Premium Oct 27, 2016 FDA Approves Use of Ventana PD-L1 Complementary Test With New Lung Cancer Immunotherapy Sep 12, 2016 Opdivo Setback May Yield Lessons for Pharma Advancing Immunotherapies With PD-L1 Testing Premium Breaking News In Brief This Week: NIH, Thermo Fisher Scientific, Biocept, Castle Biosciences, Biodesix Biological Dynamics Taps Two Firms to Study Utility, Economics of Pancreatic Cancer Detection Test FDA Grants EUAs to Lucira Health Molecular COVID/Flu Test, Azure Biotech, CorDx COVID Antigen Tests Biocare Medical Acquires Empire Genomics Meridian Bioscience Fiscal Q4 Revenues Fall 14 Percent, Full-Year Revenues Grow 5 Percent Japanese Consortium Launches Study to Evaluate Utility of Blood-Based Alzheimer's Markers
